A Healthy Volunteer Receives an Intravenous Infusion of mAb114 (IMAGE)

NIH/National Institute of Allergy and Infectious Diseases

A Healthy Volunteer Receives an Intravenous Infusion of mAb114

Caption

May 21, 2018 - A healthy volunteer receives an intravenous infusion of mAb114--an experimental treatment for Ebola virus disease--in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Md.

Credit

NIAID

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.